SHARE PURCHASE AGREEMENTShare Purchase Agreement • November 20th, 2017 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS SHARE PURCHASE AGREEMENT (the “Agreement”) is deemed to be effective as of July 31, 2017 (the “Effective Date”), by and between Jaguar Animal Health, Inc., a Delaware corporation (the “Company”), and Invesco Asset Management Limited, acting as agent for and on behalf of its discretionary managed clients (“Invesco”).
TERMINATION, ASSET TRANSFER AND TRANSITION AGREEMENT BETWEEN NAPO PHARMACEUTICALS, INC. AND GLENMARK PHARMACEUTICALS, LTD. DATED SEPTEMBER 22, 2017Termination, Asset Transfer and Transition Agreement • November 20th, 2017 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
THIS TERMINATION, ASSET TRANSFER AND TRANSITION AGREEMENT (this “Agreement”) dated as of September 22, 2017 (“Transfer Date”), is entered into between Napo Pharmaceuticals, Inc., a wholly-owned subsidiary of Jaguar Health, Inc., a Delaware corporation having its principal place of business at 201 Mission Street, Ste. 2375, San Francisco, California 94105 (“Napo”), and Glenmark Pharmaceuticals, Ltd., a company organized under the laws of the Republic of India having its principal place of business at Glenmark House, B D Sawant Marg, Chakala, Off Western Express Highway Andheri (E), Mumbai - 400099 (“Glenmark”).
